The minimum duration of pulselessness required before organ donation after circulatory determination of death has not been well studied. We conducted a prospective observational study of the incidence ...
MARLBOROUGH, Mass., April 16, 2025--(BUSINESS WIRE)--CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, announced the continuation of the ...